View our latest research stories.

October 2, 2018 Research Highlights

Impact of State Policies for Prescription Drug Monitoring Programs on High-Risk Opioid Prescriptions

A recent study in Health Affairs by CHERISH Research Affiliate Dr. Yuhua Bao and CHERISH investigators Dr. Zachary Meisel and Dr. Bruce Schackman examined the impact of prescription drug monitoring program policies on high-risk opioid prescriptions. Prescription drug monitoring programs (PDMPs) are statewide databases of controlled substances dispensed at retail pharmacies. Currently, all states and Washington D.C. except Missouri […]

June 14, 2017 Policy Watch

CHERISH Conference on Substance Use Disorder Treatment Research

In the opening plenary panel of the CHERISH (Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV and HIV) conference on evidence-based policy and practice are (l to r) Daniel Polsky, PhD, moderator and Executive Director of the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI); Tom McLellan, PhD, Chairman of the Board and […]

November 29, 2016 Profile Feature

CHERISH Profiled at the Liver Meeting® 2016

The Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV (CHERISH) was profiled at the Liver Meeting® 2016 in Boston, MA. The Center’s mission is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy and HCV and […]

December 16, 2015 Research Highlights

Quality of Life of Opioid Users and their Spouses

There are more deaths in the US from opioids than from any other unintentional injury–one person died every 30 minutes from an opioid analgesic overdose in the US in 2014. The experience of living with opioid use is harmful both for the opioid user and for his or her spouse. A recent study published in the journal Addiction quantified […]

August 18, 2015 Profile Feature

Center for Health Economics of Treatment for Substance Users Is Established at Weill Cornell Medical College

The high costs of treating the more than 7 million people with a substance use disorder may be daunting to public and private payers. The costs of not treating them may be even higher, especially if you consider the costs of failing to screen for and treat HIV and hepatitis C in this population. Sorting […]

Engage with CHERISH

Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.